Research Roundtable: Advancements in Earlier Detection of Pancreatic Cancer

Too many patients with pancreatic cancer are diagnosed too late, when the disease has spread and surgery is no longer an option. Researchers have been trying to unravel this challenge for decades and now, new tools and technology are providing optimism for earlier detection strategies that improve outcomes.

On World Pancreatic Cancer Day, PanCAN Chief Scientific and Medical Officer Anna Berkenblit, MD, MMSc, hosted a roundtable discussion with top researchers and leaders in the field who are working to transform how we identify people at high risk for the disease and detect pancreatic cancer at an earlier stage, when it's more treatable.

View the recording to learn more about:

• The potential of artificial intelligence (AI) to more accurately identify people at high risk for the disease and to help detect pancreatic cancer earlier
• New blood tests under development focused on earlier detection of pancreatic cancer and other types of cancer
• The latest on other innovative screening advancements
• PanCAN's Early Detection Initiative, a groundbreaking study exploring the connection between high blood sugar and pancreatic cancer

Anna Berkenblit, MD, MMSc

PanCAN Chief Scientific and Medical Officer responsible for the organization's overall scientific and clinical strategy, including PanCAN-sponsored studies, research grants, health data, business development and patient services.

Sudheer Doss, PhD

PanCAN Chief Business Officer overseeing business development activities associated with PanCAN's scientific and medical affairs program. He is also responsible for the organization's health data/AI strategy for all patient data generated from PanCAN's scientific and medical affairs initiatives.

Erkut Borazanci, MD, MS

Director of Oncology, HonorHealth Research Institute; Research Professor, John Shufeldt School of Medicine and Advanced Medical Engineering, Arizona State University

Michael Goggins, MD

Sol Goldman Professor for Pancreatic Cancer Research; Director, Pancreatic Cancer Early Detection Laboratory, Johns Hopkins University

Bechien Wu, MD, MPH

Gastroenterologist specializing in pancreatology at Kaiser Permanente Los Angeles Medical Center; Physician Director, Division of Clinician Research, Southern California Medical Group; Professor, Department of Clinical Science, Kaiser Permanente School of Medicine

*PanCAN does not endorse any company, product, test or drug. All topics discussed during this webinar are for informational purposes only and should not be considered medical advice. Contact PanCAN Patient Services and your healthcare team to learn more.